| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.33 | 0.03 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.04 |